This page includes the latest FDA filings for Acerus Pharmaceuticals Corp. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| CANADA | TORONTO STOCK EXCHANGE | ASP | DUNS 243912362 |
Device Company | Device | Date |
|---|---|---|
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2025-07-26 |
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2025-04-03 |
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2022-12-20 |
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2021-12-23 |
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-11-14 |
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-05-21 |
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-05-19 |
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-05-16 |
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-05-15 |
| Acerus Pharmaceuticals Corporation | Natesto | 2020-05-08 |
| NCAGE Code | L0MW0 | ACERUS PHARMACEUTICALS CORPORATION |
| SEC | 0001527246 | Acerus Pharmaceuticals Corp of ONTARIO, CANADA |